# Use of the Combination of Sumatriptan and Naproxen in the Acute Treatment of Migraine: Real World Evidence Study

> **NCT06868953** · — · NOT_YET_RECRUITING · sponsor: **IRCCS San Raffaele Roma** · enrollment: 300 (estimated)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** combination of sumatriptan 85 mg and naproxen 500 mg

## Key facts

- **NCT ID:** NCT06868953
- **Lead sponsor:** IRCCS San Raffaele Roma
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-10
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06868953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06868953, "Use of the Combination of Sumatriptan and Naproxen in the Acute Treatment of Migraine: Real World Evidence Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06868953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*